SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-022095
Filing Date
2020-02-14
Accepted
2020-02-14 18:03:11
Documents
2
Period of Report
2020-02-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm208184d1_form3.html 3  
1 OWNERSHIP DOCUMENT tm208184d1_form3.xml 3 1630
2 EXHIBIT 24 tm208184d1_ex24.htm EX-24 7050
  Complete submission text file 0001104659-20-022095.txt   10281
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARIAD PHARMACEUTICALS 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Schlesinger Sarah J. (Reporting) CIK: 0001579873 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37544 | Film No.: 20622362